Cargando…
Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-Resistance by Feature Extraction of Gray Level Co-Occurrence Matrix Using Optical Images
Ovarian cancer is the most malignant of all gynecological cancers. A challenge that deteriorates with ovarian adenocarcinoma in neoplastic disease patients has been associated with the chemoresistance of cancer cells. Cisplatin (CP) belongs to the first-line chemotherapeutic agents and it would be b...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345158/ https://www.ncbi.nlm.nih.gov/pubmed/32527052 http://dx.doi.org/10.3390/diagnostics10060389 |
_version_ | 1783556115400753152 |
---|---|
author | Huang, Chih-Ling Lian, Meng-Jia Wu, Yi-Hsuan Chen, Wei-Ming Chiu, Wen-Tai |
author_facet | Huang, Chih-Ling Lian, Meng-Jia Wu, Yi-Hsuan Chen, Wei-Ming Chiu, Wen-Tai |
author_sort | Huang, Chih-Ling |
collection | PubMed |
description | Ovarian cancer is the most malignant of all gynecological cancers. A challenge that deteriorates with ovarian adenocarcinoma in neoplastic disease patients has been associated with the chemoresistance of cancer cells. Cisplatin (CP) belongs to the first-line chemotherapeutic agents and it would be beneficial to identify chemoresistance for ovarian adenocarcinoma cells, especially CP-resistance. Gray level co-occurrence matrix (GLCM) was characterized imaging from a numeric matrix and find its texture features. Serous type (OVCAR-4 and A2780), and clear cell type (IGROV1) ovarian carcinoma cell lines with CP-resistance were used to demonstrate GLCM texture feature extraction of images. Cells were cultured with cell density of 6 × 10(5) in a glass-bottom dish to form a uniform coverage of the glass slide to get the optical images by microscope and DVC camera. CP-resistant cells included OVCAR-4, A2780 and IGROV and had the higher contrast and entropy, lower energy, and homogeneity. Signal to noise ratio was used to evaluate the degree for chemoresistance of cell images based on GLCM texture feature extraction. The difference between wile type and CP-resistant cells was statistically significant in every case (p < 0.001). It is a promising model to achieve a rapid method with a more reliable diagnostic performance for identification of ovarian adenocarcinoma cells with CP-resistance by feature extraction of GLCM in vitro or ex vivo. |
format | Online Article Text |
id | pubmed-7345158 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73451582020-07-09 Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-Resistance by Feature Extraction of Gray Level Co-Occurrence Matrix Using Optical Images Huang, Chih-Ling Lian, Meng-Jia Wu, Yi-Hsuan Chen, Wei-Ming Chiu, Wen-Tai Diagnostics (Basel) Article Ovarian cancer is the most malignant of all gynecological cancers. A challenge that deteriorates with ovarian adenocarcinoma in neoplastic disease patients has been associated with the chemoresistance of cancer cells. Cisplatin (CP) belongs to the first-line chemotherapeutic agents and it would be beneficial to identify chemoresistance for ovarian adenocarcinoma cells, especially CP-resistance. Gray level co-occurrence matrix (GLCM) was characterized imaging from a numeric matrix and find its texture features. Serous type (OVCAR-4 and A2780), and clear cell type (IGROV1) ovarian carcinoma cell lines with CP-resistance were used to demonstrate GLCM texture feature extraction of images. Cells were cultured with cell density of 6 × 10(5) in a glass-bottom dish to form a uniform coverage of the glass slide to get the optical images by microscope and DVC camera. CP-resistant cells included OVCAR-4, A2780 and IGROV and had the higher contrast and entropy, lower energy, and homogeneity. Signal to noise ratio was used to evaluate the degree for chemoresistance of cell images based on GLCM texture feature extraction. The difference between wile type and CP-resistant cells was statistically significant in every case (p < 0.001). It is a promising model to achieve a rapid method with a more reliable diagnostic performance for identification of ovarian adenocarcinoma cells with CP-resistance by feature extraction of GLCM in vitro or ex vivo. MDPI 2020-06-09 /pmc/articles/PMC7345158/ /pubmed/32527052 http://dx.doi.org/10.3390/diagnostics10060389 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Huang, Chih-Ling Lian, Meng-Jia Wu, Yi-Hsuan Chen, Wei-Ming Chiu, Wen-Tai Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-Resistance by Feature Extraction of Gray Level Co-Occurrence Matrix Using Optical Images |
title | Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-Resistance by Feature Extraction of Gray Level Co-Occurrence Matrix Using Optical Images |
title_full | Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-Resistance by Feature Extraction of Gray Level Co-Occurrence Matrix Using Optical Images |
title_fullStr | Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-Resistance by Feature Extraction of Gray Level Co-Occurrence Matrix Using Optical Images |
title_full_unstemmed | Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-Resistance by Feature Extraction of Gray Level Co-Occurrence Matrix Using Optical Images |
title_short | Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-Resistance by Feature Extraction of Gray Level Co-Occurrence Matrix Using Optical Images |
title_sort | identification of human ovarian adenocarcinoma cells with cisplatin-resistance by feature extraction of gray level co-occurrence matrix using optical images |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345158/ https://www.ncbi.nlm.nih.gov/pubmed/32527052 http://dx.doi.org/10.3390/diagnostics10060389 |
work_keys_str_mv | AT huangchihling identificationofhumanovarianadenocarcinomacellswithcisplatinresistancebyfeatureextractionofgraylevelcooccurrencematrixusingopticalimages AT lianmengjia identificationofhumanovarianadenocarcinomacellswithcisplatinresistancebyfeatureextractionofgraylevelcooccurrencematrixusingopticalimages AT wuyihsuan identificationofhumanovarianadenocarcinomacellswithcisplatinresistancebyfeatureextractionofgraylevelcooccurrencematrixusingopticalimages AT chenweiming identificationofhumanovarianadenocarcinomacellswithcisplatinresistancebyfeatureextractionofgraylevelcooccurrencematrixusingopticalimages AT chiuwentai identificationofhumanovarianadenocarcinomacellswithcisplatinresistancebyfeatureextractionofgraylevelcooccurrencematrixusingopticalimages |